Blau Farmacêutica S.A. (BLAU3.SA)

BRL 12.57

(-5.42%)

Operating Income Summary of Blau Farmacêutica S.A.

Blau Farmacêutica S.A.'s latest annual operating income in 2023 was 211.53 Million BRL , down -58.73% from previous year.
Blau Farmacêutica S.A.'s latest quarterly operating income in 2024 Q2 was 81.69 Million BRL , up 95.31% from previous quarter.
Blau Farmacêutica S.A. reported an annual operating income of 512.6 Million BRL in 2022, up 4.56% from previous year.
Blau Farmacêutica S.A. reported an annual operating income of 490.23 Million BRL in 2021, up 33.61% from previous year.
Blau Farmacêutica S.A. reported a quarterly operating income of 41.82 Million BRL for 2024 Q1, down -0.69% from previous quarter.
Blau Farmacêutica S.A. reported a quarterly operating income of -71.77 Million BRL for 2023 Q3, down -172.86% from previous quarter.

Annual Operating Income Chart of Blau Farmacêutica S.A. (2023 - 2015)

Historical Annual Operating Income of Blau Farmacêutica S.A. (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	211.53 Million BRL	-58.73%
2022	512.6 Million BRL	4.56%
2021	490.23 Million BRL	33.61%
2020	366.9 Million BRL	21.78%
2019	301.29 Million BRL	54.64%
2018	194.83 Million BRL	21.14%
2017	160.83 Million BRL	109.44%
2016	76.79 Million BRL	39.78%
2015	54.93 Million BRL	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	81.69 Million BRL	95.31%
2024 Q1	41.82 Million BRL	-0.69%
2023 Q3	-71.77 Million BRL	-172.86%
2023 Q1	64.76 Million BRL	-48.35%
2023 Q2	98.51 Million BRL	52.1%
2023 Q4	42.11 Million BRL	158.68%
2023 FY	211.53 Million BRL	-58.73%
2022 FY	512.6 Million BRL	4.56%
2022 Q4	125.4 Million BRL	-5.35%
2022 Q3	132.49 Million BRL	11.6%
2022 Q2	118.72 Million BRL	19.58%
2022 Q1	99.28 Million BRL	-0.87%
2021 Q4	100.15 Million BRL	-26.55%
2021 Q1	116.92 Million BRL	3.64%
2021 Q3	136.37 Million BRL	-8.06%
2021 Q2	148.32 Million BRL	26.86%
2021 FY	490.23 Million BRL	33.61%
2020 Q2	109.44 Million BRL	156.26%
2020 FY	366.9 Million BRL	21.78%
2020 Q4	112.81 Million BRL	2.73%
2020 Q3	109.81 Million BRL	0.34%
2020 Q1	42.7 Million BRL	-48.25%
2019 Q3	87.03 Million BRL	-12.07%
2019 Q2	98.98 Million BRL	119.07%
2019 Q1	45.18 Million BRL	-32.18%
2019 FY	301.29 Million BRL	54.64%
2019 Q4	82.53 Million BRL	-5.17%
2018 Q2	40.9 Million BRL	16.29%
2018 FY	194.83 Million BRL	21.14%
2018 Q4	66.61 Million BRL	-6.15%
2018 Q3	70.98 Million BRL	73.55%
2018 Q1	35.17 Million BRL	0.0%
2017 FY	160.83 Million BRL	109.44%
2016 FY	76.79 Million BRL	39.78%
2015 FY	54.93 Million BRL	0.0%

Peer Operating Income Comparison of Blau Farmacêutica S.A.

Name	Operating Income	Operating Income Difference
Hypera S.A.	2.28 Billion BRL	90.743%